Marylène Lejeune (Lejeune Marylene)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

Cancers

Histochemistry and cell biology

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of imaging informatics in medicine

Hospital de Tortosa Verge de la Cinta

Free University of Brussels (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital de Tortosa Verge de la Cinta Aug 01 2006

Spain

Investigador / coordinator :: Molecular Biology and Research section

Hospital de Tortosa Verge de la Cinta Jan 01 2003 - Jul 31 2006

Spain

Grant holder position :: Anatomy Pathology Department

Hospital Clínic y Provincial de Barcelona Jan 01 1999 - Jun 30 2002

Spain

Grant holder position :: Department of Immunology

Saint-Pierre University hospital

Belgium

Researcher position :: Department of Hematology,

Education History

Free University of Brussels

Belgium

PHD :: Faculty of Medicine and Pharmacy

Free University of Brussels

Belgium

BSC :: Faculty of Medicine and Pharmacy

Publications

Alessio Fiorin, Carlos López-Pablo, Marylène Lejeune, Ameer Hamza Siraj, Vincenzo Della Mea
Enhancing AI Research for Breast Cancer: A Comprehensive Review of Tumor-Infiltrating Lymphocyte Datasets. Journal of imaging informatics in medicine (2024)
Marylène Lejeune, Laia Reverté, Esther Sauras, Noèlia Gallardo, Ramon Bosch, Albert Roso, Anna Petit, Vicente Peg, Francisco Riu, Joan García-Fontgivell, José Ibáñez, Fernanda Relea, Begoña Vieites, Catherine Bor, Luis de la Cruz Merino, Meritxell Arenas, Valerie Rodriguez, Juana Galera, Anna Korzynska, Philippe Belhomme, Benoît Plancoulaine, Tomás Álvaro, Carlos López
Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response. Cancers 15 (3) (2023)
Marylène Lejeune, Laia Reverté, Esther Sauras, Noèlia Gallardo, Ramon Bosch, Albert Roso, Anna Petit, Vicente Peg, Francisco Riu, Joan García-Fontgivell, José Ibáñez, Fernanda Relea, Begoña Vieites, Catherine Bor, Luis de la Cruz Merino, Meritxell Arenas, Valerie Rodriguez, Juana Galera, Anna Korzynska, Philippe Belhomme, Benoît Plancoulaine, Tomás Álvaro, Carlos López
Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response. Cancers 15 (3) (2023)
Marylène Lejeune, Laia Reverté, Noèlia Gallardo, Esther Sauras, Ramon Bosch, Daniel Mata, Albert Roso, Anna Petit, Vicente Peg, Francisco Riu, Joan García-Fontgivell, Fernanda Relea, Begoña Vieites, Luis de la Cruz Merino, Meritxell Arenas, Valeri Rodriguez, Juana Galera, Anna Korzynska, Benoît Plancoulaine, Tomás Álvaro, Carlos López
Matrix Metalloproteinase-9 Expression Is Associated with the Absence of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients. International journal of molecular sciences 24 (14) (2023)
Natalia Palazón-Carrión, Alejandro Martín García-Sancho, Esteban Nogales-Fernández, Carlos Jiménez-Cortegana, Fernando Carnicero-González, Eduardo Ríos-Herranz, Fátima de la Cruz-Vicente, Guillermo Rodríguez-García, Rubén Fernández-Álvarez, Natividad Martínez-Banaclocha, Josep Gumà Padró, José Gómez-Codina, Antonio Salar-Silvestre, Delvys Rodríguez-Abreu, Laura Gálvez Carvajal, Jorge Labrador-Gomez, María Guirado-Risueño, Daniel José García-Domínguez, Lourdes Hontecillas-Prieto, Pablo Espejo-García, Isabel Fernández-Román, Mariano Provencio Pulla, Margarita Sánchez-Beato, Marta Navarro, Marylène Lejeune, Tomás Álvaro-Naranjo, Maria Casanova-Espinosa, Víctor Sánchez-Margalet, Antonio Rueda-Domínguez, Luis de la Cruz Merino
Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (17) (2022)
Ximena Terra, Victoria Ceperuelo-Mallafré, Carla Merma-Linares, Ester Benaiges, Ramon Bosch, Paola Castillo, Joan Carles Flores, Xavier Leon Vintro, Izaskun Valduvieco, Neus Basté, Marina Cámara, Marylène Lejeune, Josep Gumà, Joan Vendrell, Isabel Vilaseca, Sonia Fernández-Veledo, Francesc Xavier Avilés-Jurado
Succinate Pathway in Head and Neck Squamous Cell Carcinoma: Potential as a Diagnostic and Prognostic Marker. Cancers 13 (7) (2021)
Marylène Lejeune, Benoît Plancoulaine, Nicolas Elie, Ramon Bosch, Laia Fontoura, Izar de Villasante, Anna Korzynska, Andrea Gras Navarro, Esther Sauras Colón, Carlos López-Pablo
How the variability between computer-assisted analysis procedures evaluating immune markers can influence patients' outcome prediction. Histochemistry and cell biology 156 (5) (2021)
Albert Gibert-Ramos, Carlos López-Pablo, Ramon Bosch, Laia Fontoura, Gloria Bueno, Marcial García-Rojo, Marta Berenguer, Marylène Lejeune
Immune response profile of primary tumour, sentinel and non-sentinel axillary lymph nodes related to metastasis in breast cancer: an immunohistochemical point of view. Histochemistry and cell biology 152 (3) (2019)

Marylène Lejeune.css-eqlu8i{font-size:small;padding-left:4px;} (Lejeune Marylene)

Publication Activity (10 Years)

Top Topics

Top Venues

Marylène Lejeune (Lejeune Marylene)